Active Ingredients, Intermediates and Compounds

Product Lifecycle Management - Maximizing Profit and Leveraging Innovation

The cost of developing a new drug is continuously rising. Many other factors, such as stricter regulations and stronger global competition, are also creating major challenges. If a pharmaceutical company intends to increase its market share and return

Vetter Pharma International

Vetter Case Study - Speeding Up Time to Market

In the hyper-competitive pharmaceuticals and biotechnology markets, companies face a litany of challenges, from stricter regulatory guidelines and rising development costs to the pressures of globalization. To succeed under these conditions, pharmaceuticals

Vetter Pharma International

Lifeline Industries: Active Pharmaceutical Ingredients, Intermediates and Reaction Capabilities

Lifeline Industries, a pharmaceutical manufacturer represented by Euro Pharma, has recently started production of a range of new APIs. The company also manufactures intermediates, and has an impressive range of reaction capabilities. All of Lifeline

Euro Pharma

ENAMINE Libraries for Fragment-Based Drug Discovery

The Fragment-Based Approach to Drug Discovery (FBDD) has been established as an efficient tool in the search for new drugs. Understanding the increasing importance of the FBDD for modern pharmaceutical industry, we set a goal to design a

Enamine